Sareum Holdings Investor Relations Material
Latest events
H1 2025
Sareum Holdings
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Sareum Holdings plc
Access all reports
Sareum Holdings plc is a UK-based biotechnology company focused on the discovery and development of small molecule therapeutics targeting cancer and autoimmune diseases. The company specializes in kinase inhibition and advances its drug candidates through preclinical and early clinical development stages. Sareum’s lead programs target immune and inflammation pathways, and the company collaborates with partners to support further development and commercialization. Sareum Holdings plc is headquartered in Cambridge, United Kingdom, and its shares are listed on the AIM.
Key slides for Sareum Holdings plc
H2 2024
Sareum Holdings plc
H1 2025
Sareum Holdings plc
Latest articles
)
Adobe: Equipping the Architects of Digital Expression
The story of how Adobe grew from a small garage upstart to one of the largest and most dominant software companies in the world.
21 Mar 2025
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
Ticker symbol
SAR
Country
🇬🇧 United Kingdom